Topographic expression of the Hippo transducers TAZ and YAP in triple-negative breast cancer treated with neoadjuvant chemotherapy

被引：0
|
作者：
Patrizia Vici
Cristiana Ercolani
Anna Di Benedetto
Laura Pizzuti
Luigi Di Lauro
Francesca Sperati
Irene Terrenato
Teresa Gamucci
Clara Natoli
Franco Di Filippo
Claudio Botti
Maddalena Barba
Marcella Mottolese
Ruggero De Maria
Marcello Maugeri-Saccà
机构：
[1] “Regina Elena” National Cancer Institute,Division of Medical Oncology B
[2] “Regina Elena” National Cancer Institute,Department of Pathology
[3] “Regina Elena” National Cancer Institute,Biostatistics
[4] ASL Frosinone,Scientific Direction
[5] University “G. d’Annunzio”,Medical Oncology Unit
[6] “Regina Elena” National Cancer Institute,Department of Experimental and Clinical Sciences
[7] “Regina Elena” National Cancer Institute,Department of Surgery
[8] “Regina Elena” National Cancer Institute,Scientific Direction
来源：
Journal of Experimental & Clinical Cancer Research | / 35卷
关键词：
Hippo pathway; TAZ; YAP; Triple-negative breast cancer; Stromal cells;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Topographic expression of the Hippo transducers TAZ and YAP in triple-negative breast cancer treated with neoadjuvant chemotherapy
    Vici, Patrizia
    Ercolani, Cristiana
    Di Benedetto, Anna
    Pizzuti, Laura
    Di Lauro, Luigi
    Sperati, Francesca
    Terrenato, Irene
    Gamucci, Teresa
    Natoli, Clara
    Di Filippo, Franco
    Botti, Claudio
    Barba, Maddalena
    Mottolese, Marcella
    De Maria, Ruggero
    Maugeri-Sacca, Marcello
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2016, 35
  • [2] The Hippo transducers TAZ/YAP and their target CTGF in male breast cancer
    Di Benedetto, Anna
    Mottolese, Marcella
    Sperati, Francesca
    Ercolani, Cristiana
    Di Lauro, Luigi
    Pizzuti, Laura
    Vici, Patrizia
    Terrenato, Irene
    Sperduti, Isabella
    Shaaban, Abeer M.
    Sundara-Rajan, Sreekumar
    Barba, Maddalena
    Speirs, Valerie
    De Maria, Ruggero
    Maugeri-Sacca, Marcello
    ONCOTARGET, 2016, 7 (28) : 43188 - 43198
  • [3] Nuclear TAZ expression associates with the triple-negative phenotype in breast cancer
    Diaz-Martin, Juan
    Angeles Lopez-Garcia, Maria
    Romero-Perez, Laura
    Reina Atienza-Amores, Maria
    Luisa Pecero, Maria
    Angeles Castilla, Maria
    Biscuola, Michele
    Santon, Almudena
    Palacios, Jose
    ENDOCRINE-RELATED CANCER, 2015, 22 (03) : 443 - 454
  • [4] Analysis of the hippo transducers TAZ and YAP in cervical cancer and its microenvironment
    Buglioni, Simonetta
    Vici, Patrizia
    Sergi, Domenico
    Pizzuti, Laura
    Di Lauro, Luigi
    Antoniani, Barbara
    Sperati, Francesca
    Terrenato, Irene
    Carosi, Mariantonia
    Gamucci, Teresa
    Vincenzoni, Cristina
    Mariani, Luciano
    Vizza, Enrico
    Venuti, Aldo
    Sanguineti, Giuseppe
    Gadducci, Angiolo
    Barba, Maddalena
    Natoli, Clara
    Vitale, Ilio
    Mottolese, Marcella
    De Maria, Ruggero
    Maugeri-Sacca, Marcello
    ONCOIMMUNOLOGY, 2016, 5 (06):
  • [5] Androgen receptor expression and outcome of neoadjuvant chemotherapy in triple-negative breast cancer
    Di Leone, A.
    Fragomeni, S. M.
    Scardina, L.
    Ionta, L.
    Mule, A.
    Magno, S.
    Terribile, D.
    Masetti, R.
    Franceschini, G.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (04) : 1910 - 1915
  • [6] Synaptopodin-2 suppresses metastasis of triple-negative breast cancer via inhibition of YAP/TAZ activity
    Liu, Junling
    Ye, Liping
    Li, Qingyuan
    Wu, Xianqiu
    Wang, Bin
    Ouyang, Ying
    Yuan, Zhongyu
    Li, Jun
    Lin, Chuyong
    JOURNAL OF PATHOLOGY, 2018, 244 (01) : 71 - 83
  • [7] Neoadjuvant and Adjuvant Chemotherapy Considerations for Triple-Negative Breast Cancer
    Stover, Daniel G.
    Bell, Caitlin F.
    Tolaney, Sara M.
    AMERICAN JOURNAL OF HEMATOLOGY-ONCOLOGY, 2016, 12 (03) : 6 - 12
  • [8] Adjuvant and Neoadjuvant Treatment of Triple-Negative Breast Cancer With Chemotherapy
    Marra, Antonio
    Curigliano, Giuseppe
    CANCER JOURNAL, 2021, 27 (01) : 41 - 49
  • [9] Knockdown of TAZ modifies triple-negative breast cancer cell sensitivity to EGFR inhibitors by regulating YAP expression
    Guo, Liwen
    Zheng, Jiaping
    Zhang, Jing
    Wang, Haohao
    Shao, Guoliang
    Teng, Lisong
    ONCOLOGY REPORTS, 2016, 36 (02) : 729 - 736
  • [10] ETS1 is a prognostic biomarker of triple-negative breast cancer and promotes the triple-negative breast cancer progression through the YAP signaling
    Li, Yanlin
    Wu, Tiantian
    Peng, Ziluo
    Tian, Xianyan
    Dai, Qian
    Chen, Miao
    Zhu, Jun
    Xia, Song
    Sun, Aiqin
    Yang, Wannian
    Lin, Qiong
    AMERICAN JOURNAL OF CANCER RESEARCH, 2022, 12 (11): : 5074 - 5084
12345